Home » BAXTER RECEIVES TENTATIVE FDA APPROVALS FOR ONDANSETRON INJECTION IN VIALS AND PREMIX CONTAINERS
BAXTER RECEIVES TENTATIVE FDA APPROVALS FOR ONDANSETRON INJECTION IN VIALS AND PREMIX CONTAINERS
Baxter Healthcare Corporation today announced that it has received tentative approvals from the U.S. Food and Drug Administration (FDA) for ondansetron injection USP, including the first tentative approval for a premix version of GlaxoSmithKline's Zofran, which is used for the prevention of nausea and vomiting.
Doctor's
Guide
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May